곰팡이 단백질 시장 - 세계 산업 규모, 점유율, 동향, 기회, 예측 : 유형, 성질, 용도, 지역별, 경쟁(2021-2031년)

The Global Fungal Protein Market is projected to expand significantly, rising from USD 4.11 Billion in 2025 to USD 5.87 Billion by 2031, demonstrating a compound annual growth rate of 6.12%. Fungal protein, a sustainable food ingredient, is produced through the fermentation of fungi like Fusarium venenatum, yielding fibrous alternatives to meat. This market expansion is primarily fueled by the critical global demand for resource-efficient food systems and a growing consumer preference for ethically sourced, animal-free proteins. These factors represent enduring, structural shifts within the global food supply rather than transient market fads. For instance, data from the Good Food Institute indicates that approximately 50% of French consumers in 2025 were receptive to products derived from precision fermentation, underscoring the category's expanding commercial promise.

Despite this promising outlook, the sector faces a substantial hurdle in the form of high capital investment necessary for achieving scalability. The construction of industrial bioreactors entails considerable upfront expenses, preventing manufacturers from achieving price competitiveness with conventional meat products. This financial barrier effectively constrains rapid production capacity expansion and hinders producers' ability to cater to the broader mass market. Consequently, optimizing production economics remains a formidable impediment to the industry's widespread growth.

Market Driver

Surging capital investments and strategic alliances are fundamentally transforming the fungal protein sector, facilitating its transition from pilot-scale operations to full commercial production. These financial inflows are crucial for overcoming the substantial initial costs associated with constructing bioreactors and establishing downstream processing infrastructure. For example, Infinite Roots announced in January 2024 that it secured $58 million in Series B financing, specifically to scale its mycelium fermentation technologies and broaden its global reach. This funding enables companies to refine production efficiencies and build essential supply chain networks. Furthermore, the Good Food Institute reported that the wider fermentation-enabled protein sector attracted $515 million in capital funding during the preceding year (2023), highlighting sustained investor confidence despite broader economic instability.

A secondary yet potent catalyst for market growth is the increasing diversification of meat alternative and ready-to-eat product portfolios, which directly enhances consumer access to fungal-based foods. Manufacturers are proactively expanding their product lines to include whole-cut analogs and convenient meal solutions that accurately replicate the texture and nutritional profile of animal proteins. This proliferation in retail is vital for transitioning fungal proteins from specialized health food outlets to mainstream distribution channels. An illustrative example of this rapid distribution growth is Meati Foods, which in April 2024 announced a successful expansion of its product availability to 6,000 retail locations across the United States. Such strategic expansions validate the commercial viability of mycelium products and encourage greater retailer adoption, thereby creating a positive feedback loop that stimulates further production capacity and innovation.

Market Challenge

The substantial capital investment required to scale production infrastructure represents a significant impediment to the growth of the Global Fungal Protein Market. Manufacturers encounter immense upfront costs when attempting to upgrade from pilot-scale facilities to industrial-grade bioreactors, which are essential for supplying mass-market volumes. This financial burden prevents companies from achieving the necessary economies of scale to reduce unit costs and attain price parity with traditional animal proteins. As a result, the elevated price point of fungal protein products restricts their adoption to a limited consumer segment, thereby impeding broader market penetration and commercial viability.

The insufficient funding available to support these capital-intensive projects directly slows the industry's expansion. According to the Good Food Institute, the global fermentation sector attracted approximately $651 million in total private funding in 2024. While this sum indicates ongoing interest, it represents a finite pool of capital that must be allocated across research, operations, and infrastructure throughout the entire industry. This level of investment is currently inadequate to finance the widespread construction of commercial-scale facilities needed to effectively disrupt the global food supply chain. Consequently, the market's growth trajectory is hindered by producers' physical inability to generate the volumes required to trigger critical cost reductions.

Market Trends

The Global Fungal Protein Market is experiencing a transformation in production methodologies through the adoption of circular economy models that utilize upcycled agro-industrial feedstocks. Producers are strategically moving away from costly, refined sugar substrates, instead valorizing industrial sidestreams, such as food processing waste, to cultivate high-quality biomass. This shift significantly lowers operational expenditures while simultaneously enhancing the environmental sustainability of their ingredients. The proven feasibility of this approach is driving considerable infrastructure development focused on converting low-value byproducts into premium protein. A notable example is the Finnish biotech startup Enifer, which, as reported by Green Queen in May 2024, secured total financing of €36 million in 2024 to construct a commercial facility specifically designed to produce mycoprotein from food industry sidestreams.

Concurrently, a new product category is emerging with the development of hybrid fungal and plant-based protein formulations, designed to cater to both strict vegetarians and flexitarians. Rather than solely replacing meat, these hybrid solutions integrate mycelium with animal proteins or plant bases to improve texture, moisture retention, and nutritional density. This "meat-plus" strategy addresses common sensory shortcomings found in pure plant-based alternatives by leveraging fungi's natural fibrous structure to better mimic the mouthfeel of conventional muscle tissue. Highlighting this commercial direction, AgFunderNews reported in January 2024 that Mush Foods commercially launched its 50CUT mycelium blends in the United States, which are engineered to reduce the animal meat content in ground beef products by 50% while fully preserving flavor integrity.

Key Market Players

• Cayman Chemical Company
• CHIHONBIO CO., LTD.
• Duke Thomson's India Pvt. Ltd
• DuPont de Nemours, Inc.
• Virgin Galactic Holdings Inc
• Mayasan Gida Sanayi ve Ticaret A.S
• Merck KGaA
• dsm-firmenich AG
• Santa Cruz Biotechnology, Inc
• Siveele B.V.

Report Scope

In this report, the Global Fungal Protein Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Fungal Protein Market, By Type

• Yeast
• Fusarium Venenatum

Fungal Protein Market, By Nature

• Organic
• Conventional

Fungal Protein Market, By Application

• Food and beverages
• Animal Nutrition
• Pharmaceuticals
• Others

Fungal Protein Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Fungal Protein Market.

Available Customizations:

Global Fungal Protein Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Fungal Protein Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (Yeast, Fusarium Venenatum)
  • 5.2.2. By Nature (Organic, Conventional)
  • 5.2.3. By Application (Food and beverages, Animal Nutrition, Pharmaceuticals, Others)
  • 5.2.4. By Region
  • 5.2.5. By Company (2025)
• 5.3. Market Map

6. North America Fungal Protein Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By Nature
  • 6.2.3. By Application
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Fungal Protein Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By Nature
      • 6.3.1.2.3. By Application
  • 6.3.2. Canada Fungal Protein Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By Nature
      • 6.3.2.2.3. By Application
  • 6.3.3. Mexico Fungal Protein Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By Nature
      • 6.3.3.2.3. By Application

7. Europe Fungal Protein Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By Nature
  • 7.2.3. By Application
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Fungal Protein Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Nature
      • 7.3.1.2.3. By Application
  • 7.3.2. France Fungal Protein Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Nature
      • 7.3.2.2.3. By Application
  • 7.3.3. United Kingdom Fungal Protein Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Nature
      • 7.3.3.2.3. By Application
  • 7.3.4. Italy Fungal Protein Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By Nature
      • 7.3.4.2.3. By Application
  • 7.3.5. Spain Fungal Protein Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By Nature
      • 7.3.5.2.3. By Application

8. Asia Pacific Fungal Protein Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By Nature
  • 8.2.3. By Application
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Fungal Protein Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Nature
      • 8.3.1.2.3. By Application
  • 8.3.2. India Fungal Protein Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Nature
      • 8.3.2.2.3. By Application
  • 8.3.3. Japan Fungal Protein Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Nature
      • 8.3.3.2.3. By Application
  • 8.3.4. South Korea Fungal Protein Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By Nature
      • 8.3.4.2.3. By Application
  • 8.3.5. Australia Fungal Protein Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By Nature
      • 8.3.5.2.3. By Application

9. Middle East & Africa Fungal Protein Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By Nature
  • 9.2.3. By Application
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Fungal Protein Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Nature
      • 9.3.1.2.3. By Application
  • 9.3.2. UAE Fungal Protein Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Nature
      • 9.3.2.2.3. By Application
  • 9.3.3. South Africa Fungal Protein Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Nature
      • 9.3.3.2.3. By Application

10. South America Fungal Protein Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By Nature
  • 10.2.3. By Application
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Fungal Protein Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By Nature
      • 10.3.1.2.3. By Application
  • 10.3.2. Colombia Fungal Protein Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By Nature
      • 10.3.2.2.3. By Application
  • 10.3.3. Argentina Fungal Protein Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By Nature
      • 10.3.3.2.3. By Application

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Fungal Protein Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Cayman Chemical Company
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. CHIHONBIO CO., LTD.
• 15.3. Duke Thomson's India Pvt. Ltd
• 15.4. DuPont de Nemours, Inc.
• 15.5. Virgin Galactic Holdings Inc
• 15.6. Mayasan Gida Sanayi ve Ticaret A.S
• 15.7. Merck KGaA
• 15.8. dsm-firmenich AG
• 15.9. Santa Cruz Biotechnology, Inc
• 15.10. Siveele B.V.

16. Strategic Recommendations

17. About Us & Disclaimer